Abstract:Objectives BackgroundSCN5A is encoding human sodium channel protein Nav1.5. Mutations on SCN5A have been found to induce multiple fatal arrhythmia syndromes, such as Long QT syndrome (LQTS), atrioventricular block (AVB) and Brugada syndrome. This study aimed to explore the pathogenic spectrum, characteristics and therapeutic outcomes of the syndromes caused by mutations on SCN5A.MethodsOne LQT3 kindred and an AVB kindred from the Chinese National Channelopathy Registry Study were investigated. Blood samples and clinical data were obtained under written consents. Mutational screening of SCN5A gene was performed via PCR and direct DNA sequence analysis. LQTS or AVB phenotype and therapeutic outcomes were evaluated for all probands and family members. Genotype-phenotype evaluation was also performed for family members. Mutational analyses were based on NCBI standardised mRNA sequence (SCN5A: NM_198056.2).ResultsThe LQTS proband was a 1-year-old girl (test-tube baby). She had her first syncope at 9-month-old in night sleep. Afterwards several episodes of syncope occurred, often accompanied by Torsades de Pointes (TdP) and ventricular fibrillation. ECG showed a maximum QTc of 690ms, while no abnormality was found on ECG of her parents. Gene screening of SCN5A identified a novel mutation F1473S (4418 T>C) on the proband, but this mutation was not detected on the parents, indicating a de novo mutation. Medication with propranolol (2.5 mg/kg/d) alone did not improve the symptoms. Additional use of mexiletine (12.5 mg/kg/d) showed some improvement, but syncopes still occurred now and then. Then the dosage was adjusted to propranolol (2.5 mg/kg/d) and mexilatine (15 mg/kg/d). The girl died at 23-month-old, though the external defibrillator was used at home. The AVB proband is a 57-year-old male. He showed symptoms of bradycardia, short of breath and even inability to lie down. ECG indicated complete right bundle branch block (RBBB) and left anterior fascicular block. He has received pacemaker implantation in March of 2011 and no symptoms occurred since then. A novel mutation F919L (2757C>A) on SCN5A was found. No AVB related symptoms were found on his family members, except for RBBB showed in the ECG of his son and brother. Gene screening detected the same mutation in both persons. To note, the proband9s father had sudden death at age of 57, but no DNA sample is available to determine his genotype.ConclusionsThe present study revealed two novel mutations, F1473S and F919L on SCN5A, which have not been reported. The two novel mutations induced distinct but equally lethal arrhythmia syndromes, LQTS and AVB, respectively. In consider of the reports in western countries of relatively severe LQTS-causing mutation F1473C (4418 T>G) on SCN5A, we may also conclude that the site SCN5A1473 is a mutational “hot spot”, which characterises an early onset and severe phenotype of LQT3.

In Silico Investigation of the CACNA1C N2091S Mutation in Timothy Syndrome.

Loss of Luminal Ca 2+ Activation in the Cardiac Ryanodine Receptor is Associated with Ventricular Fibrillation and Sudden Death

Enhanced Basal Activity of a Cardiac Ca2+ Release Channel (ryanodine Receptor) Mutant Associated with Ventricular Tachycardia and Sudden Death.

KCNQ1 Gain-of-function Mutation in Familial Atrial Fibrillation

Patient-specific Ipsc-Derived Cardiomyocytes Reveal Aberrant Activation of Wnt/β-catenin Signaling in SCN5A-related Brugada Syndrome

Novel Timothy syndrome mutation leading to increase in CACNA1C window current.

Characterization of the CACNA1C-R518C Missense Mutation in the Pathobiology of Long-QT Syndrome Using Human Induced Pluripotent Stem Cell Cardiomyocytes Shows Action Potential Prolongation and L-Type Calcium Channel Perturbation.

Α-1-syntrophin Mutation and the Long-QT Syndrome

Molecular and Functional Characterization of Rare CACNA1C Variants in Sudden Unexplained Death in the Young.

Abstract P1037: Dysfunction Of N-terminal Acetylation Causes Multiple Electrical Abnormalities Leading To Long QT Syndrome And Dilated Cardiomyopathy

Identification and Functional Characterization of a Novel CACNA1C -Mediated Cardiac Disorder Characterized by Prolonged QT Intervals with Hypertrophic Cardiomyopathy, Congenital Heart Defects, and Sudden Cardiac Death

Altered Cardiac Sodium Channel Function Resulting from Voltage-Sensor Mutation is a Risk Factor for Dilated Cardiomyopathy

Case Report: A Novel Variant c.2262+3A>T of the SCN5A Gene Results in Intron Retention Associated With Incessant Ventricular Tachycardias

Altered firing activity of intracardiac neurons isolated from mice carrying the Scn5a-1798insD mutation

A mutation in the CACNA1C gene leads to early repolarization syndrome with incomplete penetrance: A Chinese family study

NOVEL MUTATIONS ON SCN5A CAUSED FATAL ARRHYTHMIA SYNDROME IN CHINESE

Higher Sodium Channel Excitability in Cardiac Purkinje Fibers: Implications for Multifocal Ectopic Purkinje-Related Premature Contractions.

A Pore-Localizing CACNA1C-E1115K Missense Mutation, Identified in a Patient with Idiopathic QT Prolongation, Bradycardia, and Autism Spectrum Disorder, Converts the L-type Calcium Channel into a Hybrid Nonselective Monovalent Cation Channel.

Patient-specific Induced Pluripotent Stem Cell Properties Implicate Ca2+-homeostasis in Clinical Arrhythmia Associated with Combined Heterozygous RYR2 and SCN10A Variants.

The SCN5A point mutation M1875T, associated with familial atrial fibrillation, causes a gain-of-function effect of the cardiac Nav1.5 channel in atrial cardiomyocytes

Alterations of Nedd4-2-binding Capacity in PY-motif of NaV 1.5 Channel Underlie Long QT Syndrome and Brugada Syndrome.